{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:21:37Z","timestamp":1789986097373,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T00:00:00Z","timestamp":1409875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T00:00:00Z","timestamp":1409875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12630-014-0227-5","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T01:15:21Z","timestamp":1409879721000},"page":"1040-1049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference","Hyperthermie maligne et signification clinique des variants du g\u00e8ne du r\u00e9cepteur de la ryanodine de type\u00a01 (RYR1): comptes rendus de la conf\u00e9rence scientifique 2013 de la MHAUS"],"prefix":"10.1007","volume":"61","author":[{"given":"Sheila","family":"Riazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kraeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila M.","family":"Muldoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Alexandra","family":"Petre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Parness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Dirksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,5]]},"reference":[{"key":"227_CR1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/BF03004695","volume":"17","author":"BA Britt","year":"1970","unstructured":"Britt BA, Kalow W. Malignant hyperthermia: aetiology unknown. Can Anaesth Soc J 1970; 17: 316-30.","journal-title":"Can Anaesth Soc J"},{"key":"227_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"H Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis 2007; 2: 21.","journal-title":"Orphanet J Rare Dis"},{"key":"227_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1589759","volume":"256","author":"DH MacLennan","year":"1992","unstructured":"MacLennan DH, Phillips MS. Malignant hyperthermia. Science 1992; 256: 789-94.","journal-title":"Science"},{"key":"227_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/bja\/34.6.395","volume":"34","author":"MA Denborough","year":"1962","unstructured":"Denborough MA, Forster JF, Lovell RR, Maplestone PA, Villiers JD. Anaesthetic deaths in a family. Br J Anaesth 1962; 34: 395-6.","journal-title":"Br J Anaesth"},{"key":"227_CR5","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"R Robinson","year":"2006","unstructured":"Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006; 27: 977-89.","journal-title":"Hum Mutat"},{"key":"227_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1213\/ANE.0b013e31828a71ff","volume":"116","author":"BW Brandom","year":"2013","unstructured":"Brandom BW, Bina S, Wong C, et al. Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States. Anesth Analg 2013; 116: 1078-86.","journal-title":"Anesth Analg"},{"key":"227_CR7","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.bbamcr.2010.11.009","volume":"1813","author":"DH Maclennan","year":"2011","unstructured":"Maclennan DH, Zvaritch E. Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim Biophys Acta 2011; 1813: 948-64.","journal-title":"Biochim Biophys Acta"},{"key":"227_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature09471","volume":"468","author":"CC Tung","year":"2010","unstructured":"Tung CC, Lobo PA, Kimlicka L, Van Petegem F. The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule. Nature 2010; 468: 585-8.","journal-title":"Nature"},{"key":"227_CR9","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1073\/pnas.032657599","volume":"99","author":"E Felder","year":"2002","unstructured":"Felder E, Franzini-Armstrong C. Type 3 ryanodine receptors of skeletal muscle are segregated in a parajunctional position. Proc Natl Acad Sci U S A 2002; 99: 1695-700.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"227_CR10","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nm.2406","volume":"17","author":"Q Zhou","year":"2011","unstructured":"Zhou Q, Xiao J, Jiang D, et al. Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. Nat Med 2011; 17: 1003-9.","journal-title":"Nat Med"},{"key":"227_CR11","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1113\/jphysiol.2009.172155","volume":"587","author":"DH MacLennan","year":"2009","unstructured":"MacLennan DH, Chen SR. Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes. J Physiol 2009; 587: 3113-5.","journal-title":"J Physiol"},{"key":"227_CR12","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1073\/pnas.1119207109","volume":"109","author":"JM Eltit","year":"2012","unstructured":"Eltit JM, Bannister R, Moua O, et al. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor. Proc Natl Acad Sci U S A 2012; 109: 7923-8.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"227_CR13","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1124\/mol.107.043299","volume":"73","author":"G Cherednichenko","year":"2008","unstructured":"Cherednichenko G, Ward CW, Feng W, et al. Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C Is attenuated by dantrolene. Mol Pharmacol 2008; 73: 1203-12.","journal-title":"Mol Pharmacol"},{"key":"227_CR14","doi-asserted-by":"publisher","first-page":"37471","DOI":"10.1074\/jbc.M701379200","volume":"282","author":"T Yang","year":"2007","unstructured":"Yang T, Allen PD, Pessah IN, Lopez JR. Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J Biol Chem 2007; 282: 37471-8.","journal-title":"J Biol Chem"},{"key":"227_CR15","doi-asserted-by":"publisher","first-page":"e77633","DOI":"10.1371\/journal.pone.0077633","volume":"8","author":"V Yarotskyy","year":"2013","unstructured":"Yarotskyy V, Protasi F, Dirksen RT. Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death. PLoS One 2013; 8: e77633.","journal-title":"PLoS One"},{"key":"227_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1750-1172-8-117","volume":"8","author":"K Amburgey","year":"2013","unstructured":"Amburgey K, Bailey A, Hwang JH, et al. Genotype-phenotype correlations in recessive RYR1-related myopathies. Orphanet J Rare Dis 2013; 8: 117.","journal-title":"Orphanet J Rare Dis"},{"key":"227_CR17","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1001\/jamaophthalmol.2013.4392","volume":"131","author":"S Shaaban","year":"2013","unstructured":"Shaaban S, Ramos-Platt L, Gilles FH, et al. RYR1 mutations as a cause of ophthalmoplegia, facial weakness, and malignant hyperthermia. JAMA Ophthalmol 2013; 131: 1532-40.","journal-title":"JAMA Ophthalmol"},{"key":"227_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.nmd.2013.02.009","volume":"23","author":"NF Clarke","year":"2013","unstructured":"Clarke NF, Amburgey K, Teener J, et al. A novel mutation expands the genetic and clinical spectrum of MYH7-related myopathies. Neuromuscul Dis 2013; 23: 432-6.","journal-title":"Neuromuscul Dis"},{"key":"227_CR19","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/ncomms2952","volume":"4","author":"EJ Horstick","year":"2013","unstructured":"Horstick EJ, Linsley JW, Dowling JJ, et al. Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy. Nat Commun 2013; 4: 1952.","journal-title":"Nat Commun"},{"key":"227_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/aws036","volume":"135","author":"JJ Dowling","year":"2012","unstructured":"Dowling JJ, Arbogast S, Hur J, et al. Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. Brain 2012; 135: 1115-27.","journal-title":"Brain"},{"key":"227_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-394317-0.00015-7","volume":"56","author":"G Banfi","year":"2012","unstructured":"Banfi G, Colombini A, Lombardi G, Lubkowska A. Metabolic markers in sports medicine. Adv Clin Chem 2012; 56: 1-54.","journal-title":"Adv Clin Chem"},{"key":"227_CR22","doi-asserted-by":"publisher","first-page":"e32471","DOI":"10.1371\/journal.pone.0032471","volume":"7","author":"LM Brewster","year":"2012","unstructured":"Brewster LM, Coronel CM, Sluiter W, Clark JF, van Montfrans GA. Ethnic differences in tissue creatine kinase activity: an observational study. PLoS One 2012; 7: e32471.","journal-title":"PLoS One"},{"key":"227_CR23","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1213\/ane.0b013e3181a9d8d9","volume":"109","author":"JF Capacchione","year":"2009","unstructured":"Capacchione JF, Muldoon SM. The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia. Anesth Analg 2009; 109: 1065-9.","journal-title":"Anesth Analg"},{"key":"227_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1213\/ANE.0b013e3182768f99","volume":"116","author":"WA Lavezzi","year":"2013","unstructured":"Lavezzi WA, Capacchione JF, Muldoon SM, et al. Case report: Death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old. Anesth Analg 2013; 116: 420-3.","journal-title":"Anesth Analg"},{"key":"227_CR25","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/ALN.0b013e318167aee2","volume":"108","author":"MG Larach","year":"2008","unstructured":"Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States. Anesthesiology 2008; 108: 603-11.","journal-title":"Anesthesiology"},{"key":"227_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/ALN.0b013e3182320068","volume":"115","author":"L Groom","year":"2011","unstructured":"Groom L, Muldoon SM, Tang ZZ, et al. Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families. Anesthesiology 2011; 115: 938-45.","journal-title":"Anesthesiology"},{"key":"227_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/00003677-200410000-00009","volume":"32","author":"S Muldoon","year":"2004","unstructured":"Muldoon S, Deuster P, Brandom B, Bunger R. Is there a link between malignant hyperthermia and exertional heat illness? Exerc Sport Sci Rev 2004; 32: 174-9.","journal-title":"Exerc Sport Sci Rev"},{"key":"227_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/01.CSMR.0000313392.79569.e7","volume":"7","author":"S Muldoon","year":"2008","unstructured":"Muldoon S, Deuster P, Voelkel M, Capacchione J, Bunger R. Exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia: is there a link? Curr Sports Med Rep 2008; 7: 74-80.","journal-title":"Curr Sports Med Rep"},{"key":"227_CR29","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.bbrc.2005.10.108","volume":"338","author":"P Sirvent","year":"2005","unstructured":"Sirvent P, Bordenave S, Vermaelen M, et al. Simvastatin induces impairment in skeletal muscle while heart is protected. Biochem Biophys Res Commun 2005; 338: 1426-34.","journal-title":"Biochem Biophys Res Commun"},{"key":"227_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/art.22100","volume":"55","author":"S Guis","year":"2006","unstructured":"Guis S, Figarella-Branger D, Mattei JP, et al. In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effects. Arthritis Rheum 2006; 55: 551-7.","journal-title":"Arthritis Rheum"},{"key":"227_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ymgme.2011.07.001","volume":"104","author":"G Vladutiu","year":"2011","unstructured":"Vladutiu G, Isackson P, Kaufman K, et al. Genetic risk for malignant hyperthermia in non-anesthesia-induced myopathies. Mol Genet Metab 2011; 104: 167-73.","journal-title":"Mol Genet Metab"},{"key":"227_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/2044-5040-3-22","volume":"3","author":"M Knoblauch","year":"2013","unstructured":"Knoblauch M, Dagnino-Acosta A, Hamilton SL. Mice with RyR1 mutation (Y524S) undergo hypermetabolic response to simvastatin. Skelet Muscle 2013; 3: 22.","journal-title":"Skelet Muscle"},{"key":"227_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","volume":"110","author":"MG Larach","year":"2010","unstructured":"Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg 2010; 110: 498-507.","journal-title":"Anesth Analg"},{"key":"227_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","volume":"118","author":"S Riazi","year":"2014","unstructured":"Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg 2014; 118: 381-7.","journal-title":"Anesth Analg"},{"key":"227_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","volume":"69","author":"MG Larach","year":"1989","unstructured":"Larach MG. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group. Anesth Analg 1989; 69: 511-5.","journal-title":"Anesth Analg"},{"key":"227_CR36","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","volume":"41","author":"H Ording","year":"1997","unstructured":"Ording H, Brancadoro V, Cozzolino S, et al. In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 1997; 41: 955-66.","journal-title":"Acta Anaesthesiol Scand"},{"key":"227_CR37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","volume":"80","author":"MG Larach","year":"1994","unstructured":"Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994; 80: 771-9.","journal-title":"Anesthesiology"},{"key":"227_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","volume":"10","author":"CS Richards","year":"2008","unstructured":"Richards CS, Bale S, Bellissimo DB, et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med 2008; 10: 294-300.","journal-title":"Genet Med"},{"key":"227_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013; 15: 565-74.","journal-title":"Genet Med"},{"key":"227_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1161\/CIRCGENETICS.113.000085","volume":"6","author":"J Punetha","year":"2013","unstructured":"Punetha J, Hoffman EP. Short read (next-generation) sequencing: a tutorial with cardiomyopathy diagnostics as an exemplar. Circ Cardiovasc Genet 2013; 6: 427-34.","journal-title":"Circ Cardiovasc Genet"},{"key":"227_CR41","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/ALN.0b013e3182a8a998","volume":"119","author":"JH Kim","year":"2013","unstructured":"Kim JH, Jarvik GP, Browning BL, et al. Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families. Anesthesiology 2013; 119: 1054-65.","journal-title":"Anesthesiology"},{"key":"227_CR42","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/ALN.0b013e3182a8a8e7","volume":"119","author":"SG Gonsalves","year":"2013","unstructured":"Gonsalves SG, Ng D, Johnston JJ, et al. Using exome data to identify malignant hyperthermia susceptibility mutations. Anesthesiology 2013; 119: 1043-53.","journal-title":"Anesthesiology"},{"key":"227_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1440-1819.1998.00416.x","volume":"52","author":"Y Tsutsumi","year":"1998","unstructured":"Tsutsumi Y, Yamamoto K, Matsuura S, Hata S, Sakai M, Shirakura K. The treatment of neuroleptic malignant syndrome using dantrolene sodium. Psychiatry Clin Neurosci 1998; 52: 433-8.","journal-title":"Psychiatry Clin Neurosci"},{"key":"227_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1530-0277.1997.tb03729.x","volume":"21","author":"M Pagala","year":"1997","unstructured":"Pagala M, Amaladevi B, Bernstein A, Herzlich B, Namba T, Grob D. Dantrolene sodium reduces the enhanced leakage of creatine kinase caused by ethanol, cocaine, and electrical stimulation in isolated fast and slow muscles of rat. Alcohol Clin Exp Res 1997; 21: 63-7.","journal-title":"Alcohol Clin Exp Res"},{"key":"227_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nm.2598","volume":"18","author":"JT Lanner","year":"2012","unstructured":"Lanner JT, Georgiou DK, Dagnino-Acosta A, et al. AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation. Nat Med 2012; 18: 244-51.","journal-title":"Nat Med"},{"key":"227_CR46","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/clpt.2013.218","volume":"95","author":"AS Kesselheim","year":"2014","unstructured":"Kesselheim AS, Gagne JJ. Strategies for postmarketing surveillance of drugs for rare diseases. Clin Pharmacol Ther 2014; 95: 265-8.","journal-title":"Clin Pharmacol Ther"},{"key":"227_CR47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cct.2010.06.007","volume":"31","author":"YR Rubinstein","year":"2010","unstructured":"Rubinstein YR, Groft SC, Bartek R, et al. Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB). Contemp Clin Trials 2010; 31: 394-404.","journal-title":"Contemp Clin Trials"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-014-0227-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12630-014-0227-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-014-0227-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-014-0227-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T11:27:54Z","timestamp":1678102074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12630-014-0227-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,5]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["227"],"URL":"https:\/\/doi.org\/10.1007\/s12630-014-0227-5","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,5]]},"assertion":[{"value":"2 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}